Results 21 to 30 of about 2,043 (190)

Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies [PDF]

open access: yes, 2018
Hyperphosphatemic familial tumoral calcinosis (HFTC)/hyperostosis-hyperphosphatemia syndrome (HHS) is an autosomal recessive disorder of ectopic calcification due to deficiency of or resistance to intact fibroblast growth factor 23 (iFGF23). Inactivating
Burbelo   +14 more
core   +1 more source

Conditional Deletion of Murine Fgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia [PDF]

open access: yes, 2016
The transgenic and knockout (KO) animals involving Fgf23 have been highly informative in defining novel aspects of mineral metabolism, but are limited by shortened lifespan, inability of spatial/temporal FGF23 control, and infertility of the global KO ...
Allen, Matthew R.   +6 more
core   +1 more source

Systemic Control of Bone Homeostasis by FGF23 Signaling [PDF]

open access: yes, 2016
The regulation of phosphate metabolism as an influence on bone homeostasis is profound. Recent advances in understanding the systemic control of Fibroblast growth factor-23 (FGF23) has uncovered novel effectors of endocrine feedback loops for calcium ...
Clinkenbeard, Erica L.   +1 more
core   +1 more source

Hypophosphatemic rickets: Revealing Novel Control Points for Phosphate Homeostasis [PDF]

open access: yes, 2014
Rapid and somewhat surprising advances have recently been made towards understanding the molecular mechanisms causing heritable disorders of hypophosphatemia.
Econs, Michael J.   +2 more
core   +1 more source

An unusual case of familial hypophosphatemic rickets

open access: yesInternational Journal of Contemporary Pediatrics, 2023
Rickets is the failure of mineralisation of osteoid and newly formed bones in a child skeleton. It is commonly associated with vitamin D deficiency; however, it can be because of a decrease in serum phosphate level leading to inadequate mineralization of cartilage and bone, consequent skeletal deformities and growth retardation.
Leny E. Bhadke   +2 more
openaire   +1 more source

Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women [PDF]

open access: yes, 2016
Fibroblast growth factor 23 (FGF23) circulates as active protein and inactive fragments. Low iron status increases FGF23 gene expression, and iron deficiency is common. We hypothesized that in healthy premenopausal women, serum iron influences C-terminal
Acton, Anthony   +7 more
core   +1 more source

Renal Fanconi Syndrome and Hypophosphatemic Rickets in the Absence of Xenotropic and Polytropic Retroviral Receptor in the Nephron. [PDF]

open access: yes, 2017
Tight control of extracellular and intracellular inorganic phosphate (Pi) levels is critical to most biochemical and physiologic processes. Urinary Pi is freely filtered at the kidney glomerulus and is reabsorbed in the renal tubule by the action of the ...
Baron, R.   +10 more
core   +1 more source

FGF23 Deficiency Leads to Mixed Hearing Loss and Middle Ear Malformation in Mice [PDF]

open access: yes, 2014
Fibroblast growth factor 23 (FGF23) is a circulating hormone important in phosphate homeostasis. Abnormal serum levels of FGF23 result in systemic pathologies in humans and mice, including renal phosphate wasting diseases and hyperphosphatemia. We sought
Caruso, Paul   +7 more
core   +2 more sources

Spring technique for correction of multilevel deformity using hexapod external fixator

open access: yesJournal of Limb Lengthening & Reconstruction, 2018
Context: Osteotomies in several parts of one long bone are recommended for correction of a long, curved, and wide-angled deformity. Hexapod external fixators (HEFs) allow for the single-stage correction of multiplanar deformity, but they are heavy ...
Leonid N Solomin   +5 more
doaj   +1 more source

The metabolic bone disease associated with the Hyp mutation is independent of osteoblastic HIF1α expression [PDF]

open access: yes, 2017
Fibroblast growth factor-23 (FGF23) controls key responses to systemic phosphate increases through its phosphaturic actions on the kidney. In addition to stimulation by phosphate, FGF23 positively responds to iron deficiency anemia and hypoxia in rodent ...
Allen, Matt   +5 more
core   +3 more sources

Home - About - Disclaimer - Privacy